At RSNA 2018, iCad showed how its ProFound AI for digital breast tomosynthesis technology might help in the ...
Genomic medicine company Lucence Diagnostics announced a new project to develop artificial intelligence (AI) algorithms for improving diagnosis and treatment of liver cancer. The goal is to combine the imaging and molecular data from liver cancer patients into smarter software tools that help physicians make better treatment decisions.Genomic medicine company Lucence Diagnostics announced a new project to develop artificial intelligence (AI) algorithms for improving diagnosis and treatment of liver cancer. The goal is to combine the imaging and molecular data from liver cancer patients into smarter software tools that help physicians make better treatment decisions.
March 12, 2019 — A simple magnetic resonance imaging (MRI) method that measures iron content can provide a more ...
Radiology departments have many different needs and face a wide variety of challenges that can impact their departments ...
Computed tomography (CT) and magnetic resonance imaging (MRI) scans are chock full of information that might be used to ...
Artificial intelligence (AI) startup company Paige.AI has been granted Breakthrough Device designation by the U.S. Food and Drug Administration (FDA) for its AI designed to enhance the clinical diagnosis and treatment of cancer. It is the first such designation for AI in cancer diagnosis publicly announced by any company, according to Paige.AI.
Despite decades of progress in breast imaging, one challenge continues to test even the most skilled radiologists ...
Anderson Regional Cancer Center in Meridian, Miss., has treated its first patient using the combination of RaySearch's treatment planning system (TPS) RayStation and Accuray's TomoTherapy Treatment Delivery System. This is the first-ever treatment in the U.S. using the two technologies in combination.
March 8, 2019 — Imaging Technology News (ITN) was named a finalist in multiple categories across print, web and other ...
Mike Ciancio, imaging systems administrator at CarolinaEast Health System in North Carolina, explains how newer ...
Bayer Radiology’s Barbara Ruhland and Thom Kinst discuss how radiology departments can address the many different ...
Karl Poterack, M.D., medical director, applied clinical informatics, Mayo Clinic, explains the role wearable devices ...
A new dosimetry monitoring service from Thermo Fisher Scientific enables medical and imaging facilities, dental offices, veterinary clinics, nuclear power plants, laboratories and other facilities with radiation safety requirements to streamline management of their safety programs.
eHealth Saskatchewan plays a vital role in providing IT services to patients, health care providers, and partners such ...
National and international ultrasound societies are urging the U.S. Food and Drug Administration to remove the “black box” from ultrasound contrast agent (UCA) labels.
Hologic Inc. announced the granting of a CE Mark to the LOCalizer wireless radio frequency identification (RFID) breast lesion localization system. This system is designed for precise and easy marking and targeting of lesions for breast-conserving surgery guidance.
Carestream Health has signed an agreement to sell its healthcare information systems (HCIS) business to Philips ...
With the passage of HB1124, South Dakota becomes the 37th state with breast density inform legislation. The law, which was signed on March 5, 2019 by Gov. Kristi Noem, goes into effect July 1, 2019.
A recent Journal of the American Medical Association (JAMA) publication1 describing the cremation of patient remains containing a radioactive material garnered considerable media attention and may have alarmed some members of the general public.
Siemens Healthineers’ new Biograph Vision positron emission tomography/computed tomography (PET/CT) system has been installed at the Hospital of the University of Pennsylvania (HUP) in Philadelphia – the first healthcare institution in the United States to install the technology.
U.S. Food and Drug Administration (FDA) Commissioner Scott Gottlieb, M.D., resigned from his position March 5 after two years on the job, but said he plans to stay on with the agency into April. According to several major news outlets, the primary reason for Gottlieb’s resignation is so that he can spend more time with his family at home in Connecticut; he had reportedly been commuting to Washington, D.C., throughout his tenure.
Cree Gaskin, M.D., professor, vice chair and associate chief medical officer, University of Virginia Health System ...
March 13, 2019 